Phase II study of a novel antifolate, N10-propargyl-5,8 dideazafolic acid (CB3717), in malignant mesothelioma. [electronic resource]

By: Contributor(s): Producer: 19861204Description: 1335-6 p. digitalISSN:
  • 0361-5960
Subject(s): In: Cancer treatment reports vol. 70
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

There are no comments on this title.

to post a comment.